Page last updated: 2024-11-05

thiotepa and Cancer of Nasopharynx

thiotepa has been researched along with Cancer of Nasopharynx in 2 studies

Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Krementz, ET1
Kokame, GM1
Smirnova, IN1

Other Studies

2 other studies available for thiotepa and Cancer of Nasopharynx

ArticleYear
Regional chemotherapy of cancer of the head and neck.
    The Laryngoscope, 1966, Volume: 76, Issue:5

    Topics: Antineoplastic Agents; Carcinoma; Chemotherapy, Cancer, Regional Perfusion; Fluorouracil; Head; Head

1966
[Results of treatment of tonsillar tumors by olivomycin].
    Antibiotiki, 1969, Volume: 14, Issue:3

    Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Chlorpromazine; Cyclophosp

1969